Search

Your search keyword '"Harreiter, Jürgen"' showing total 447 results
Start Over Author "Harreiter, Jürgen"
447 results on '"Harreiter, Jürgen"'

4. Diabetes in Women

Author

Deischinger, Carola, Harreiter, Jürgen, Kautzky-Willer, Alexandra, Maas, Angela H.E.M., editor, and Gerdts, Eva, editor

Published
2024
Full Text
View/download PDF

16. Antihyperglykämische Therapie bei Diabetes mellitus Typ 2 (Update 2023)

Author

Clodi, Martin, Abrahamian, Heidemarie, Brath, Helmut, Schernthaner, Guntram, Brix, Johann, Ludvik, Bernhard, Drexel, Heinz, Saely, Christoph H., Fasching, Peter, Rega-Kaun, Gersina, Föger, Bernhard, Francesconi, Claudia, Fröhlich-Reiterer, Elke, Kautzky-Willer, Alexandra, Harreiter, Jürgen, Luger, Anton, Resl, Michael, Riedl, Michaela, Winhofer, Yvonne, Hofer, Sabine E., Hoppichler, Friedrich, Huber, Joakim, Kaser, Susanne, Ress, Claudia, Lechleitner, Monika, Aberer, Felix, Mader, Julia K., Sourij, Harald, Toplak, Hermann, Paulweber, Bernhard, Stechemesser, Lars, Pieber, Thomas, Prager, Rudolf, Stingl, Harald, Stulnig, Thomas, Rami-Merhar, Birgit, Drexel, Heinz, Roden, Michael, Schelkshorn, Christian, Wascher, Thomas C., Weitgasser, Raimund, and Zlamal-Fortunat, Sandra

Published
2023
Full Text
View/download PDF

19. An interdisciplinary integrated specialized one‐stop outpatient clinic for idiopathic intracranial hypertension—a comprehensive assessment of clinical outcome.

Author

Bsteh, Gabriel, Macher, Stefan, Krajnc, Nik, Marik, Wolfgang, Michl, Martin, Müller, Nina, Zaic, Sina, Harreiter, Jürgen, Novak, Klaus, Wöber, Christian, and Pemp, Berthold

Subjects
MEDICAL personnel, INTRACRANIAL hypertension, BODY mass index, VISION disorders, TREATMENT effectiveness
Abstract

Background and purpose: Management of idiopathic intracranial hypertension (IIH) is complex requiring multiple specialized disciplines. In practice, this creates considerable organizational and communicational challenges for healthcare professionals and patients. Thus, an interdisciplinary integrated outpatient clinic for IIH (comprising neurology, neuroophthalmology, neuroradiology, neurosurgery and endocrinology) was established with central coordination and a one‐stop concept. Here, the aim was to evaluate the effects of this one‐stop concept on objective clinical outcome. Methods: In a retrospective cohort study, the one‐stop era with integrated care (IC) (1 July 2021 to 31 December 2022) was compared to a reference group receiving standard care (SC) (1 July 2018 to 31 December 2019) regarding visual impairment/worsening and headache improvement/freedom 6 months after diagnosis. Multivariate binary logistic regression models were used to adjust for confounders. Results: Baseline characteristics of the IC group (n = 85) and SC group (n = 81) were comparable (female 90.6% vs. 90.1%; mean age 33.6 vs. 32.8 years; median body mass index 31.8 vs. 33.0; median cerebrospinal fluid opening pressure 32 vs. 34 cmH2O; at diagnosis, visual impairment was present in 71.8% vs. 69.1% and chronic headache in 55.3% vs. 56.8% in IC vs. SC). IC was associated with a higher likelihood of achieving both headache improvement (odds ratio [OR] 2.24, 95% confidence interval [CI] 1.52–4.33, p < 0.001) and headache freedom (OR 1.75, 95% CI 1.11–3.09, p = 0.031). Regarding the risk of visual impairment and visual worsening IC was superior numerically but not statistically significantly (OR 0.87, 95% CI 0.69–1.16, p = 0.231, and OR 0.67, 95% CI 0.41–1.25, p = 0.354). Conclusions: Interdisciplinary integrated care of IIH is favourably associated with headache outcomes and potentially also visual outcomes. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

22. Sex differences in hepatic and cardiac lipid accumulation and cardiac function across a cohort with a wide range of glycemic control: A secondary, cross-sectional analysis

Author

Harreiter, Jürgen, primary, Just, Ivica, additional, Weber, Michael, additional, Klepochová, Radka, additional, Bastian, Magdalena, additional, Winhofer, Yvonne, additional, Wolf, Peter, additional, Scherer, Thomas, additional, Leutner, Michael, additional, Kosi-Trebotic, Lana, additional, Deischinger, Carola, additional, Chmelík, Marek, additional, Krebs, Michael R, additional, Trattnig, Siegfried, additional, Krššák, Martin, additional, and Kautzky-Willer, Alexandra, additional

Published
2024
Full Text
View/download PDF

23. An interdisciplinary integrated specialized one-stop outpatient clinic for idiopathic intracranial hypertension – a comprehensive assessment of patient satisfaction

Author

Bsteh, Gabriel, primary, Macher, Stefan, additional, Krajnc, Nik, additional, Marik, Wolfgang, additional, Michl, Martin, additional, Müller, Nina, additional, Zaic, Sina, additional, Harreiter, Jürgen, additional, Novak, Klaus, additional, Wöber, Christian, additional, and Pemp, Berthold, additional

Published
2024
Full Text
View/download PDF

24. An interdisciplinary integrated specialized one-stop outpatient clinic for idiopathic intracranial hypertension – an assessment of sick leave, presenteeism, and health care utilization

Author

Bsteh, Gabriel, primary, Macher, Stefan, additional, Krajnc, Nik, additional, Marik, Wolfgang, additional, Michl, Martin, additional, Müller, Nina, additional, Zaic, Sina, additional, Harreiter, Jürgen, additional, Novak, Klaus, additional, Wöber, Christian, additional, and Pemp, Berthold, additional

Published
2024
Full Text
View/download PDF

25. Perinatal Outcomes in Early and Late Gestational Diabetes Mellitus After Treatment from 24-28 weeks’ Gestation: A TOBOGM Secondary Analysis

Author

Simmons, David, primary, Immanuel, Jincy, primary, Hague, William M, primary, Teede, Helena, primary, Nolan, Christopher J., primary, J Peek, Michael, primary, R Flack, Jeff, primary, McLean, Mark, primary, Wong, Vincent, primary, J Hibbert, Emily, primary, Kautzky-Willer, Alexandra, primary, Harreiter, Jürgen, primary, Backman, Helena, primary, Gianatti, Emily, primary, Sweeting, Arianne, primary, Mohan, Viswanathan, primary, and Wah Cheung, N, primary

Published
2024
Full Text
View/download PDF

26. Association Between Immediate Treatment of Early Gestational Diabetes Mellitus and Breastfeeding Outcomes : Findings From the TOBOGM Study

Author

Seifu, Canaan Negash, Immanuel, Jincy, Hague, William M, Teede, Helena, Cheung, N Wah, Hibbert, Emily J, Nolan, Christopher J, Peek, Michael J, Wong, Vincent W, Flack, Jeff R, Mclean, Mark, Sweeting, Arianne, Kautzky-Willer, Alexandra, Harreiter, Jürgen, Gianatti, Emily, Mohan, Viswanathan, Backman, Helena, Simmons, David, Seifu, Canaan Negash, Immanuel, Jincy, Hague, William M, Teede, Helena, Cheung, N Wah, Hibbert, Emily J, Nolan, Christopher J, Peek, Michael J, Wong, Vincent W, Flack, Jeff R, Mclean, Mark, Sweeting, Arianne, Kautzky-Willer, Alexandra, Harreiter, Jürgen, Gianatti, Emily, Mohan, Viswanathan, Backman, Helena, and Simmons, David

Published
2024
Full Text
View/download PDF

27. Perinatal Outcomes in Early and Late Gestational Diabetes Mellitus After Treatment From 24-28 Weeks' Gestation : A TOBOGM Secondary Analysis

Author

Simmons, David, Immanuel, Jincy, Hague, William M, Teede, Helena, Nolan, Christopher J, Peek, Michael J, Flack, Jeff R, McLean, Mark, Wong, Vincent, Hibbert, Emily J, Kautzky-Willer, Alexandra, Harreiter, Jürgen, Backman, Helena, Gianatti, Emily, Sweeting, Arianne, Mohan, Viswanathan, Cheung, N Wah, Simmons, David, Immanuel, Jincy, Hague, William M, Teede, Helena, Nolan, Christopher J, Peek, Michael J, Flack, Jeff R, McLean, Mark, Wong, Vincent, Hibbert, Emily J, Kautzky-Willer, Alexandra, Harreiter, Jürgen, Backman, Helena, Gianatti, Emily, Sweeting, Arianne, Mohan, Viswanathan, and Cheung, N Wah

Abstract

OBJECTIVE: In most gestational diabetes mellitus (GDM) studies, cohorts have included women combined into study populations without regard to whether hyperglycemia was present earlier in pregnancy. In this study we sought to compare perinatal outcomes between groups: women with early GDM (EGDM group: diagnosis before 20 weeks but no treatment until 24-28 weeks if GDM still present), with late GDM (LGDM group: present only at 24-28 weeks), and with normoglycemia at 24-28 weeks (control subjects). RESEARCH DESIGN AND METHODS: This is a secondary analysis of a randomized controlled treatment trial where we studied, among women with risk factors, early (<20 weeks' gestation) GDM defined according to World Health Organization 2013 criteria. Those receiving early treatment for GDM treatment were excluded. GDM was treated if present at 24-28 weeks. The primary outcome was a composite of birth before 37 weeks' gestation, birth weight ≥4,500 g, birth trauma, neonatal respiratory distress, phototherapy, stillbirth/neonatal death, and shoulder dystocia. Comparisons included adjustment for age, ethnicity, BMI, site, smoking, primigravity, and education. RESULTS: Women with EGDM (n = 254) and LGDM (n = 467) had shorter pregnancy duration than control subjects (n = 2,339). BMI was lowest with LGDM. The composite was increased with EGDM (odds ratio [OR] 1.59, 95% CI 1.18-2.12)) but not LGDM (OR 1.19, 95% CI 0.94-1.50). Induction of labor was higher in both GDM groups. In comparisons with control subjects there were higher birth centile, higher preterm birth rate, and higher rate of neonatal jaundice for the EGDM group (but not the LGDM group). The greatest need for insulin and/or metformin was with EGDM. CONCLUSIONS: Adverse perinatal outcomes were increased with EGDM despite treatment from 24-28 weeks' gestation, suggesting the need to initiate treatment early, and more aggressively, to reduce the effects of exposure to the more severe maternal hyperglycemia from early pregnan

Published
2024
Full Text
View/download PDF

28. Cost-effectiveness of diagnosis and treatment of early gestational diabetes mellitus : economic evaluation of the TOBOGM study, an international multicenter randomized controlled trial

Author

Haque, Mohammad M., Tannous, W. Kathy, Herman, William H., Immanuel, Jincy, Hague, William M., Teede, Helena, Enticott, Joanne, Cheung, N. Wah, Hibbert, Emily, Nolan, Christopher J., Peek, Michael J., Wong, Vincent W., Flack, Jeff R., Mclean, Mark, Sweeting, Arianne, Gianatti, Emily, Kautzky-Willer, Alexandra, Harreiter, Jürgen, Mohan, Viswanathan, Backman, Helena, Simmons, David, TOBOGM Consortium, Haque, Mohammad M., Tannous, W. Kathy, Herman, William H., Immanuel, Jincy, Hague, William M., Teede, Helena, Enticott, Joanne, Cheung, N. Wah, Hibbert, Emily, Nolan, Christopher J., Peek, Michael J., Wong, Vincent W., Flack, Jeff R., Mclean, Mark, Sweeting, Arianne, Gianatti, Emily, Kautzky-Willer, Alexandra, Harreiter, Jürgen, Mohan, Viswanathan, Backman, Helena, Simmons, David, and TOBOGM Consortium

Abstract

BACKGROUND: A recently undertaken multicenter randomized controlled trial (RCT) "Treatment Of BOoking Gestational diabetes Mellitus" (TOBOGM: 2017-2022) found that the diagnosis and treatment of pregnant women with early gestational diabetes mellitus (GDM) improved pregnancy outcomes. Based on data from the trial, this study aimed to assess the cost-effectiveness of diagnosis and treatment of early GDM (from <20 weeks') among women with risk factors for hyperglycemia in pregnancy compared with usual care (no treatment until 24-28 weeks') from a healthcare perspective. METHODS: Participants' healthcare resource utilization data were collected from their self-reported questionnaires and hospital records, and valued using the unit costs obtained from standard Australian national sources. Costs were reported in US dollars ($) using the purchasing power parity (PPP) estimates to facilitate comparison of costs across countries. Intention-to-treat (ITT) principle was followed. Missing cost data were replaced using multiple imputations. Bootstrapping method was used to estimate the uncertainty around mean cost difference and cost-effectiveness results. Bootstrapped cost-effect pairs were used to plot the cost-effectiveness (CE) plane and cost-effectiveness acceptability curve (CEAC). FINDINGS: Diagnosis and treatment of early GDM was more effective and tended to be less costly, i.e., dominant (cost-saving) [-5.6% composite adverse pregnancy outcome (95% CI: -10.1%, -1.2%), -$1373 (95% CI: -$3,749, $642)] compared with usual care. Our findings were confirmed by both the CE plane (88% of the bootstrapped cost-effect pairs fall in the south-west quadrant), and CEAC (the probability of the intervention being cost-effective ranged from 84% at a willingness-to-pay (WTP) threshold value of $10,000-99% at a WTP threshold value of $100,000 per composite adverse pregnancy outcome prevented). Sub-group analyses demonstrated that diagnosis and treatment of early GDM among women in t, FUNDING: National Health and Medical Research Council (grants 1104231 and 2009326), Region O¨rebro Research Committee (grants Dnr OLL-970566 and OLL-942177), Medical Scientific Fund of the Mayor of Vienna (project 15,205 and project 23,026), South Western Sydney Local Health District Academic Unit (grant 2016), and Western Sydney University Ainsworth Trust Grant (2019).

Published
2024
Full Text
View/download PDF

29. Regression From Early GDM to Normal Glucose Tolerance and Adverse Pregnancy Outcomes in the Treatment of Booking Gestational Diabetes Mellitus Study

Author

Simmons, David, Immanuel, Jincy, Hague, William M., Teede, Helena, Nolan, Christopher J., Peek, Michael J., Flack, Jeff R., McLean, Mark, Wong, Vincent W., Hibbert, Emily J., Kautzky-Willer, Alexandra, Harreiter, Jürgen, Backman, Helena, Gianatti, Emily, Sweeting, Arianne, Mohan, Viswanathan, Cheung, N. Wah, Simmons, David, Immanuel, Jincy, Hague, William M., Teede, Helena, Nolan, Christopher J., Peek, Michael J., Flack, Jeff R., McLean, Mark, Wong, Vincent W., Hibbert, Emily J., Kautzky-Willer, Alexandra, Harreiter, Jürgen, Backman, Helena, Gianatti, Emily, Sweeting, Arianne, Mohan, Viswanathan, and Cheung, N. Wah

Abstract

OBJECTIVE: To compare pregnancy outcomes among women with a normal oral glucose tolerance test (OGTT) before 20 weeks' gestation (early) and at 24-28 weeks' gestation (late) (no gestational diabetes mellitus, or No-GDM), those with early GDM randomized to observation with a subsequent normal OGTT (GDM-Regression), and those with GDM on both occasions (GDM-Maintained). RESEARCH DESIGN AND METHODS: Women at <20 weeks' gestation with GDM risk factors who were recruited for a randomized controlled early GDM treatment trial were included. Women with treated early GDM and late GDM (according to the World Health Organization's 2013 criteria) were excluded from this analysis. Logistic regression compared pregnancy outcomes. RESULTS: GDM-Regression (n = 121) group risk factor profiles and OGTT results generally fell between the No-GDM (n = 2,218) and GDM-Maintained (n = 254) groups, with adjusted incidences of pregnancy complications similar between the GDM-Regression and No-GDM groups. CONCLUSIONS: Women with early GDM but normal OGTT at 24-28 weeks' gestation had pregnancy outcomes that were similar to those of individuals without GDM. Identifying early GDM likely to regress would allow treatment to be avoided., Funding:The National Health and Medical Research Council (NHMRC) (grants 1104231 and 2009326)The Region Örebro Research Committee (grants Dnr OLL-970566 and OLL-942177)The Medical Scientific Fund of the Mayor of Vienna (project numbers 15205 and 23026)The South Western Sydney Local Health District Academic Unit (grant 2016)Western Sydney University Ainsworth Trust grant (2019)

Published
2024
Full Text
View/download PDF

30. Less sedentary time is associated with a more favourable glucose-insulin axis in obese pregnant women—a secondary analysis of the DALI study

Author

Dieberger, Anna M., Desoye, Gernot, Stolz, Erwin, Hill, David J., Corcoy, Rosa, Simmons, David, Harreiter, Jürgen, Kautzky-Willer, Alexandra, Dunne, Fidelma, Devlieger, Roland, Wender-Ozegowska, Ewa, Zawiejska, Agnieszka, Lapolla, Annunziata, Dalfra, Maria Grazia, Bertolotto, Alessandra, Galjaard, Sander, Adelantado, Juan M., Jensen, Dorte Møller, Andersen, Lise-Lotte, Tanvig, Mette, Damm, Peter, Mathiesen, Elisabeth Reinhardt, Snoek, Frank J., Jelsma, Judith G. M., and van Poppel, Mireille N. M.

Published
2021
Full Text
View/download PDF

31. Performance of early pregnancy HbA1c for predicting gestational diabetes mellitus and adverse pregnancy outcomes in obese European women

Author

Immanuel, Jincy, Simmons, David, Desoye, Gernot, Corcoy, Rosa, Adelantado, Juan M., Devlieger, Roland, Lapolla, Annunziata, Dalfra, Maria G., Bertolotto, Alessandra, Harreiter, Jürgen, Wender-Ozegowska, Ewa, Zawiejska, Agnieszka, Dunne, Fidelma P., Damm, Peter, Mathiesen, Elisabeth R., Jensen, Dorte M., Andersen, Lise Lotte T., Hill, David J., Jelsma, Judith G.M., Snoek, Frank J., Scharnagl, Hubert, Galjaard, Sander, Kautzky-Willer, Alexandra, and VAN Poppel, Mireille N.M.

Published
2020
Full Text
View/download PDF

32. RANK links thymic regulatory T cells to fetal loss and gestational diabetes in pregnancy

Author

Paolino, Magdalena, Koglgruber, Rubina, Cronin, Shane J. F., Uribesalgo, Iris, Rauscher, Esther, Harreiter, Jürgen, and Schuster, Michael

Subjects
Thymic stromal lymphopoietin -- Causes of, Fetal death -- Diagnosis, T cells -- Causes of, Diabetes in pregnancy -- Diagnosis, Cytokine receptors -- Physiological aspects, Environmental issues, Science and technology, Zoology and wildlife conservation
Abstract

Successful pregnancies rely on adaptations within the mother.sup.1, including marked changes within the immune system.sup.2. It has long been known that the thymus, the central lymphoid organ, changes markedly during pregnancy.sup.3. However, the molecular basis and importance of this process remain largely obscure. Here we show that the osteoclast differentiation receptor RANK.sup.4,5 couples female sex hormones to the rewiring of the thymus during pregnancy. Genetic deletion of Rank (also known as Tnfrsf11a) in thymic epithelial cells results in impaired thymic involution and blunted expansion of natural regulatory T (T.sub.reg) cells in pregnant female mice. Sex hormones, in particular progesterone, drive the development of thymic T.sub.reg cells through RANK in a manner that depends on AIRE.sup.+ medullary thymic epithelial cells. The depletion of Rank in the mouse thymic epithelium results in reduced accumulation of natural T.sub.reg cells in the placenta, and an increase in the number of miscarriages. Thymic deletion of Rank also results in impaired accumulation of T.sub.reg cells in visceral adipose tissue, and is associated with enlarged adipocyte size, tissue inflammation, enhanced maternal glucose intolerance, fetal macrosomia, and a long-lasting transgenerational alteration in glucose homeostasis, which are all key hallmarks of gestational diabetes. Transplantation of T.sub.reg cells rescued fetal loss, maternal glucose intolerance and fetal macrosomia. In human pregnancies, we found that gestational diabetes also correlates with a reduced number of T.sub.reg cells in the placenta. Our findings show that RANK promotes the hormone-mediated development of thymic T.sub.reg cells during pregnancy, and expand the functional role of maternal T.sub.reg cells to the development of gestational diabetes and the transgenerational metabolic rewiring of glucose homeostasis. RANK promotes the hormone-mediated development of thymic regulatory T cells during pregnancy; loss of RANK is associated with impaired maturation of maternal regulatory T cells, leading to fetal loss and the development of gestational diabetes., Author(s): Magdalena Paolino [sup.1] [sup.2] [sup.3] , Rubina Koglgruber [sup.1] , Shane J. F. Cronin [sup.1] , Iris Uribesalgo [sup.1] , Esther Rauscher [sup.1] , Jürgen Harreiter [sup.4] , Michael [...]

Published
2021
Full Text
View/download PDF

34. Variant-specific LDL-cholesterol patterns and risk of atherosclerotic cardiovascular disease in heterozygous FH: Insights from the Austrian FH-Registry

Author

Innerhofer, Reinhold, Ebenbichler, Christoph, Baumgartner-Kaut, Margot, Esterbauer, Harald, Fasching, Peter, Ferch, Moritz, Galli, Lukas, Greber-Platzer, Susanne, Grohs, Katharina, Harreiter, Jürgen, Karall, Daniela, Kleemann, Lucas, Klein, Dominic, Krychtiuk, Konstantin, Mäser, Martin, Rega-Kaun, Gersina, Scholl-Bürgi, Sabine, Schwaiger, Elisabeth, Speidl, Walter, Stulnig, Thomas, Stögerer-Lanzenberger, Michaela, Sunder-Plassmann, Raute, Toplak, Hermann, Widhalm, Kurt, Witsch-Baumgartner, Martina, Winhofer, Yvonne, Dieplinger, Johann, and Binder, Christoph

Published
2024
Full Text
View/download PDF

36. Comment to the letter to the editor “Gremlin-1 in pregnancy and postpartum: health risk monitoring of women with gestational diabetes mellitus” by Tamayuki Kawada, published in Acta Diabetologica as a comment to the publication “Gremlin-1 in pregnancy and postpartum: relation to the fatty liver index, markers of bone health, glucose metabolism and gestational diabetes mellitus status”

Author

Deischinger, Carola, primary and Harreiter, Jürgen, additional

Published
2023
Full Text
View/download PDF

37. 6. Postpartale Therapie und Langzeitprognose

Author

Stupin, Jens H., primary, Hüseman, Dieter, additional, Kraus, Bettina, additional, Eberle, Claudia, additional, Harreiter, Jürgen, additional, Kautzky-Willer, Alexandra, additional, Klapp, Christine, additional, and Arabin, Birgit, additional

Published
2020
Full Text
View/download PDF

38. A reduction in sedentary behaviour in obese women during pregnancy reduces neonatal adiposity: the DALI randomised controlled trial

Author

van Poppel, Mireille N. M., Simmons, David, Devlieger, Roland, van Assche, F. Andre, Jans, Goele, Galjaard, Sander, Corcoy, Rosa, Adelantado, Juan M., Dunne, Fidelma, Harreiter, Jürgen, Kautzky-Willer, Alexandra, Damm, Peter, Mathiesen, Elisabeth R., Jensen, Dorte M., Andersen, Lise-Lotte, Tanvig, Mette, Lapolla, Annunziata, Dalfra, Maria G., Bertolotto, Alessandra, Wender-Ozegowska, Ewa, Zawiejska, Agnieszka, Hill, David, Snoek, Frank J., Jelsma, Judith G. M., and Desoye, Gernot

Published
2019
Full Text
View/download PDF

39. Insulintherapie bei Typ 2 Diabetes mellitus (Update 2019)

Author

Lechleitner, Monika, Clodi, Martin, Abrahamian, Heidemarie, Brath, Helmut, Brix, Johanna, Drexel, Heinz, Fasching, Peter, Föger, Bernhard, Francesconi, Claudia, Fröhlich-Reiterer, Elke, Harreiter, Jürgen, Hofer, Sabine E., Hoppichler, Friedrich, Huber, Joakim, Kaser, Susanne, Kautzky-Willer, Alexandra, Ludvik, Bernhard, Luger, Anton, Mader, Julia K., Paulweber, Bernhard, Pieber, Thomas, Prager, Rudolf, Rami-Merhar, Birgit, Resl, Michael, Riedl, Michaela, Roden, Michael, Saely, Christoph H., Schelkshorn, Christian, Schernthaner, Guntram, Sourij, Harald, Stechemesser, Lars, Stingl, Harald, Toplak, Hermann, Wascher, Thomas C., Weitgasser, Raimund, Winhofer-Stöckl, Yvonne, and Zlamal-Fortunat, Sandra

Published
2019
Full Text
View/download PDF

44. Antihyperglykämische Therapie bei Diabetes mellitus Typ 2 (Update 2019)

Author

Clodi, Martin, Abrahamian, Heidemarie, Brath, Helmut, Brix, Johanna, Drexel, Heinz, Fasching, Peter, Föger, Bernhard, Francesconi, Claudia, Fröhlich-Reiterer, Elke, Harreiter, Jürgen, Hofer, Sabine E., Hoppichler, Friedrich, Huber, Joakim, Kaser, Susanne, Kautzky-Willer, Alexandra, Lechleitner, Monika, Ludvik, Bernhard, Luger, Anton, Mader, Julia K., Paulweber, Bernhard, Pieber, Thomas, Prager, Rudolf, Rami-Merhar, Birgit, Resl, Michael, Riedl, Michaela, Roden, Michael, Saely, Christoph H., Schelkshorn, Christian, Schernthaner, Guntram, Sourij, Harald, Stechemesser, Lars, Stingl, Harald, Toplak, Hermann, Wascher, Thomas C., Weitgasser, Raimund, Winhofer-Stöckl, Yvonne, and Zlamal-Fortunat, Sandra

Published
2019
Full Text
View/download PDF

47. The relationship between body mass index and sleep in women with risk factors for gestational diabetes mellitus

Author

Reyes, Pamela Acosta, primary, Immanuel, Jincy, additional, Hague, William M., additional, Teede, Helena, additional, Hibbert, Emily, additional, Nolan, Christopher J., additional, Peek, Michael J., additional, Wong, Vincent, additional, Flack, Jeffrey R., additional, McLean, Mark, additional, Dalal, Raiyomand, additional, Harreiter, Jürgen, additional, Kautzky–Willer, Alexandra, additional, Rajagopal, Rohit, additional, Sweeting, Arianne, additional, Ross, Glynis P., additional, Cheung, Ngai Wah, additional, and Simmons, David, additional

Published
2023
Full Text
View/download PDF

49. Treatment of Gestational Diabetes Mellitus Diagnosed Early in Pregnancy

Author

Simmons, David, primary, Immanuel, Jincy, additional, Hague, William M., additional, Teede, Helena, additional, Nolan, Christopher J., additional, Peek, Michael J., additional, Flack, Jeff R., additional, McLean, Mark, additional, Wong, Vincent, additional, Hibbert, Emily, additional, Kautzky-Willer, Alexandra, additional, Harreiter, Jürgen, additional, Backman, Helena, additional, Gianatti, Emily, additional, Sweeting, Arianne, additional, Mohan, Viswanathan, additional, Enticott, Joanne, additional, and Cheung, N. Wah, additional

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results